# Pharmacology Study of Aerosolized Liposomal

> **NCT00250120** · PHASE2 · WITHDRAWN · sponsor: **University of New Mexico**

## Conditions studied

- Lung Diseases
- Cancer

## Interventions

- **DRUG:** L9NC: Liposomal 9-Nitro-20 (S)-Camptothecin

## Key facts

- **NCT ID:** NCT00250120
- **Lead sponsor:** University of New Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2003-04
- **Primary completion:** 2007-03
- **Final completion:** 2007-08
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250120, "Pharmacology Study of Aerosolized Liposomal". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00250120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*